Fera Pharmaceuticals Announces Launch of a New Ophthalmic Anti-Infective  
3/7/2012 6:51:54 AM

NEW YORK--(BUSINESS WIRE)--Fera Pharmaceuticals is pleased to announce the launch of Sulfacetamide Sodium Ophthalmic Ointment USP, 10%.

Indicated for superficial ocular infections, including conjunctivitis, Sulfacetamide, in ointment form, will be an important addition to physicians’ treatment armamentarium.